3:42 PM
 | 
Sep 13, 2018
 |  BC Week In Review  |  Financial News  |  Other Financial News

Vivo closes $635M life sciences fund

Vivo Capital said Sept. 11 it closed its oversubscribed Vivo Opportunity Fund with $635 million. The long-only public equity fund plans to...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >